BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24393364)

  • 1. Expression of B-cell-specific Moloney murine leukemia virus integration site 1 mRNA and protein in gastric cancer.
    Liu PW; Lin Y; Chen XY
    J Dig Dis; 2014 Apr; 15(4):166-73. PubMed ID: 24393364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.
    Wu C; Zheng X; Li X; Fesler A; Hu W; Chen L; Xu B; Wang Q; Tong A; Burke S; Ju J; Jiang J
    Oncotarget; 2016 Mar; 7(12):14522-36. PubMed ID: 26894855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological significance of Bmi-1 expression in pathogenesis and progression of gastric carcinomas.
    Lu H; Sun HZ; Li H; Cong M
    Asian Pac J Cancer Prev; 2012; 13(7):3437-41. PubMed ID: 22994774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell-specific Moloney murine leukemia virus integration site 1 knockdown impairs adriamycin resistance of gastric cancer cells.
    Ma N; Zhao S; Yang W; Wang Y
    Arab J Gastroenterol; 2023 Aug; 24(3):168-174. PubMed ID: 36878814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.
    Chen Y; Lian G; Ou G; Yang K; Chen J; Li H; Chen S; Li J; Zeng L; Huang K
    Gastric Cancer; 2016 Apr; 19(2):392-402. PubMed ID: 25764514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.
    Liu F; Cao QH; Lu DJ; Luo B; Lu XF; Luo RC; Wang XG
    Oncotarget; 2015 May; 6(13):11585-99. PubMed ID: 25839162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
    Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
    J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
    Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of CD147 and E-cadherin in human gastric carcinoma].
    Wang LL; Yao GY; Zhang BY; Zhang XM; Zhao M
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):515-9. PubMed ID: 19950699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
    Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
    Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.
    Matsukawa Y; Semba S; Kato H; Ito A; Yanagihara K; Yokozaki H
    Cancer Sci; 2006 Jun; 97(6):484-91. PubMed ID: 16734726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
    Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
    Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of RUNX3 regulation in human gastric cancer.
    Friedrich MJ; Rad R; Langer R; Voland P; Hoefler H; Schmid RM; Prinz C; Gerhard M
    J Pathol; 2006 Oct; 210(2):141-6. PubMed ID: 16917803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.